期刊文献+

老年慢性阻塞性肺病急性加重期痰培养病原菌及药敏分析 被引量:8

Organism Distribution and Drug Sensitivity in the Period of Acute Exacerbation of the Elderly Patients with Chronic Obstructive Pulmonary
在线阅读 下载PDF
导出
摘要 目的:对老年性慢性阻塞性肺疾病急性加重期(AECOPD)患者痰培养病原菌类别及药敏进行分析。方法:回顾了本院2013年5月-2014年4月39例老年AECOPD患者的痰标本细菌培养和药敏报告,对所分离出来的革兰氏阴性杆菌(GNB)进行分类。结果:老年AECOPD患者痰培养显示以革兰氏阴性杆菌为主,占88.0%,其中以非发酵菌为主,占51.6%,其次为肠杆菌属,细菌依次为铜绿假单胞菌、鲍曼溶血不动杆菌、肺炎克雷伯菌。药敏试验显示大多数革兰氏阴性杆菌对新喹诺酮类、氨基糖甙类、美罗培南等抗生素敏感。结论:革兰氏阴性杆菌是老年人慢性阻塞性肺病急性加重期主要致病菌,只有根据药敏结果,才能更好地经验性用药,达到有效的治疗目的。 Objective: To summarize the character of pathogen and drug sensitivity of phlegmy plant in the elderly patients with chronic obstructive pulmonary. Method: Bacteria isolated from sputum of 39 older AECOPD patients and results of the susceptibility of antibacterial were analyzed. Result: Most bacteria in the sputum samples were gram stain negative bacillus ( GNB ), occupied 88.0% percent, and non-ferment bacteria occupied the highest rate ( 51.6% ), while enterobacteriaceae were the second. The first three bacteria were Pseudomonas aeruginosa, Acinetobacter baumanni and Klebsiella pneumonia. The results of the antibacterial susceptibility revealed that most of the GNB were sensitive to quinolone, aminoglycosides, and carbapenems..Conclusion: GNB are the main organism in the elderly patients which are in the period of acute exacerbation of COPD.Antibioic should be selected according to the character of the elderly patients, which can achieve effective therapeutic purposes.
作者 刘娜
出处 《中国医学创新》 CAS 2014年第26期107-109,共3页 Medical Innovation of China
关键词 老年人 慢性阻塞性肺病 病原菌 药敏分析 The elderly COPD Pathogen Drug sensitivity
  • 相关文献

参考文献10

二级参考文献44

共引文献85

同被引文献65

  • 1律清丽,郑委,董树.老年慢性阻塞性肺疾病合并左心衰竭诊治经验[J].齐齐哈尔医学院学报,2009,30(4):409-410. 被引量:6
  • 2王利平,肖振军.老年慢性阻塞性肺病急性加重期痰培养病原菌及药敏分析[J].晓庄学院学报(医学版),2005,2(1):59-61. 被引量:4
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8245
  • 4中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺病(COPD)诊治规范[J].全科医学临床与教育,2013,11(6):603-607.
  • 5Romme EA, Smeenk FW, Rutten EP, et al. Osteoporosis in chronic obstructive pul- monary disease[J]. Expert Rev Respir Med, 2013, 7(4): 397-410.
  • 6高润霖,吴宁,胡大一,等.心血管病治疗指南和建议[M].北京:人民军医出版社,2009:18-20.
  • 7Romme EA, Smeenk FW, Rutten EP, et al. Osteoporosis in chro- nic obstructive pulmonary disease [ J ]. Expert Rev Respir Med, 2013, 7 (4) : 397 -410.
  • 8Rothberg MB, Pekow PS, Lahti M, et al. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease [ J ]. IAMA, 2010, 303 (20) : 2035 - 2042.
  • 9Matera MG, Calzetta L, Cazzola M. 13-Adrenoceptor Modulation in Chronic Obstructive Pulmonary Disease: Present and Future Per- spectives [J]. Drugs, 2013, 73 (15): 1653-1663.
  • 10Vestbo J,Hurd SS,Agustf AG,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary. American Journal of Respiratory and Critical Care Medicine . 2013

引证文献8

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部